Skip to main content Help with accessibility Skip to main navigation

All Guidance

BwD
Adopted
BP
Adopted
CSR
Adopted
EL
Adopted
FW
Adopted
GP
Adopted
MB
Adopted
WL
Adopted

Second Generation Long-acting Injection (LAI) Antipsychotics

Date Posted: 01 - February - 2019
BNF chapter: Central nervous system

The purpose of this guidance is to provide clarity on the approval process for the prescribing of the second-generation antipsychotic long-acting injections within Lancashire Care NHS Foundation Trust. 

BwD
Adopted
BP
Pending
CSR
Adopted
EL
Adopted
FW
Pending
GP
Adopted
MB
Adopted
WL
Not adopted

Tapentadol MR

Date Posted: 01 - September - 2016
BNF chapter: Central nervous system

This position statement relates to the use of tapentadol MR for the following indications:

1. As a treatment option for intractable neuropathic pain in non-palliative care patients
2. As a treatment for nonspecific pain

 


Supporting Documents:

Tapentadol Non Palliative Neuropathic Pain New Medicine Assessment